All Stories

  1. Emergence of vancomycin-resistant Enterococcus faecium vanA ST612 with reduced daptomycin susceptibility, Switzerland, 2018 to 2024

    Article • Eurosurveillance, November 2025, European Centre for Disease Control and Prevention (ECDC)

    Dr Peter Michael Keller

  2. Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens

    Article • Journal of Medical Virology, December 2024, Wiley

    Dr Peter Michael Keller

  3. Antibacterial Effects of X-ray and MRI Contrast Media: An In Vitro Pilot Study

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    Dr Peter Michael Keller

  4. Biomolecules capturing live bacteria from clinical samples

    Article • Trends in Biochemical Sciences, August 2022, Elsevier

    Dr Peter Michael Keller

  5. Urine Flow Cytometry Parameter Cannot Safely Predict Contamination of Urine—A Cohort Study of a Swiss Emergency Department Using Machine Learning Techniques

    Article • Diagnostics, April 2022, MDPI AG

    Dr Peter Michael Keller

  6. Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producer

    Article • Journal of Global Antimicrobial Resistance, December 2021, Elsevier

    Dr Peter Michael Keller

  7. Mycobacterium helveticum sp. nov., a novel slowly growing mycobacterial species associated with granulomatous lesions in adult swine

    Article • INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, December 2020, Society for General Microbiology

    Dr Peter Michael Keller

  8. Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori

    Article • Frontiers in Cellular and Infection Microbiology, December 2020, Frontiers

    Dr Peter Michael Keller, Dr Thomas Bodmer

  9. NGS-Based S. aureus Typing and Outbreak Analysis in Clinical Microbiology Laboratories: Lessons Learned From a Swiss-Wide Proficiency Test

    Article • Frontiers in Microbiology, November 2020, Frontiers

    Dr Christophe Dessimoz, Dr Peter Michael Keller

  10. Recurrent Mycobacterium chelonae Skin Infection Unmasked as Factitious Disorder Using Bacterial Whole Genome Sequence Analysis

    Article • Open Forum Infectious Diseases, October 2020, Oxford University Press (OUP)

    Dr Peter Michael Keller

  11. Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients

    Article • Antimicrobial Agents and Chemotherapy, October 2020, ASM Journals

    Dr Peter Michael Keller

  12. Rapid Increase of CTX-M-Producing Shigella sonnei Isolates in Switzerland Due to Spread of Common Plasmids and International Clones

    Article • Antimicrobial Agents and Chemotherapy, September 2020, ASM Journals

    Dr Peter Michael Keller, Dr Thomas Bodmer

  13. Think tuberculosis—but is thinking enough?

    Article • The Lancet Infectious Diseases, June 2020, Elsevier

    Dr Peter Michael Keller

  14. Shifting Paradigms Regarding the Role of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis Advanced Lung Disease

    Article • The Journal of Heart and Lung Transplantation, April 2020, Elsevier

    Dr Peter Michael Keller

  15. International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass

    Article • Journal of Hospital Infection, February 2020, Elsevier

    Dr Peter Michael Keller

  16. Mycoplasma penetrans bacteremia in an immunocompromised patient detected by metagenomic sequencing: a case report

    Article • BMC Infectious Diseases, January 2020, Springer Science + Business Media

    Dr Peter Michael Keller

  17. Evaluation of the AID AmpC line probe assay for molecular detection of AmpC-producing Enterobacterales

    Article • Journal of Global Antimicrobial Resistance, December 2019, Elsevier

    Dr Peter Michael Keller

  18. Detection of NDM-19, a novel variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity under zinc-limited conditions, in Switzerland

    Article • Diagnostic Microbiology and Infectious Disease, November 2019, Elsevier

    Dr Peter Michael Keller

  19. Defining threshold values in microscopic examination and qPCR for optimal performance of line probe assays for resistance detection in Mycobacterium tuberculosis complex

    Article • Diagnostic Microbiology and Infectious Disease, October 2019, Elsevier

    Dr Peter Michael Keller

  20. Next-Generation Sequencing for the Diagnosis of Challenging Culture-Negative Endocarditis

    Article • Frontiers in Medicine, September 2019, Frontiers

    Dr Peter Michael Keller

  21. Review of current diagnostic methods and advances inHelicobacter pyloridiagnostics in the era of next generation sequencing

    Article • World Journal of Gastroenterology, August 2019, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Peter Michael Keller

  22. Rare Case of Community-Acquired Endocarditis Caused by Neisseria meningitidis Assessed by Clinical Metagenomics

    Article • Frontiers in Cardiovascular Medicine, August 2019, Frontiers

    Dr Peter Michael Keller

  23. Francisella tularensis Periprosthetic Joint Infections Diagnosed with Growth in Cultures

    Article • Journal of Clinical Microbiology, August 2019, ASM Journals

    Dr Peter Michael Keller

  24. Population-based inference of aminoglycoside resistance mechanisms in Escherichia coli

    Article • EBioMedicine, August 2019, Elsevier

    Dr Peter Michael Keller

  25. First Clinical Case of In Vivo Acquisition of DHA-1 Plasmid-Mediated AmpC in a Salmonella enterica subsp. enterica Isolate

    Article • Antimicrobial Agents and Chemotherapy, July 2019, ASM Journals

    Dr Peter Michael Keller

  26. Rapid Characterization of Virulence Determinants in Helicobacter pylori Isolated from Non-Atrophic Gastritis Patients by Next-Generation Sequencing

    Article • Journal of Clinical Medicine, July 2019, MDPI AG

    Dr Peter Michael Keller

  27. Phenotypic and Genomic Analyses ofBurkholderia stabilisClinical Contamination, Switzerland

    Article • Emerging Infectious Diseases, June 2019, Centers for Disease Control and Prevention (CDC)

    Dr Peter Michael Keller

  28. Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, April 2019, ASM Journals

    Dr Peter Michael Keller

  29. Standards for MIC testing that apply to the majority of bacterial pathogens should also be enforced for Mycobacterium tuberculosis complex

    Article • Clinical Microbiology and Infection, April 2019, Elsevier

    Dr Peter Michael Keller

  30. High-throughput screening of bacterial pathogens in clinical specimens using 16S rDNA qPCR and fragment analysis

    Article • Diagnostic Microbiology and Infectious Disease, April 2019, Elsevier

    Dr Peter Michael Keller

  31. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study

    Article • The Lancet Infectious Diseases, March 2019, Elsevier

    Dr Peter Michael Keller

  32. Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients

    Article • Clinical Microbiology and Infection, March 2019, Elsevier

    Dr Peter Michael Keller

  33. Rapid identification of NDM-, KPC-, IMP-, VIM- and OXA-48-like carbapenemase-producing Enterobacteriales from blood cultures by a multiplex lateral flow immunoassay

    Article • Journal of Antimicrobial Chemotherapy, February 2019, Oxford University Press (OUP)

    Dr Peter Michael Keller

  34. Low-grade infections as a possible cause of arthrofibrosis after total knee arthroplasty

    Article • Patient Safety in Surgery, January 2019, Springer Science + Business Media

    Dr Peter Michael Keller

  35. Discovery and Characterization of Mycobacterium basiliense sp. nov., a Nontuberculous Mycobacterium Isolated From Human Lungs

    Article • Frontiers in Microbiology, January 2019, Frontiers

    Dr Peter Michael Keller

  36. Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in Helicobacter pylori

    Article • Journal of Clinical Medicine, January 2019, MDPI AG

    Dr Peter Michael Keller

  37. Improving the quality and workflow of bacterial genome sequencing and analysis: paving the way for a Switzerland-wide molecular epidemiological surveillance platform

    Article • Swiss Medical Weekly, January 2019, SMW Supporting Association

    Dr Peter Michael Keller

  38. Inadequate Perioperative Prophylaxis and Postsurgical Complications After Graft Implantation Are Important Risk Factors for Subsequent Vascular Graft Infections: Prospective Results From the Vascular Graft Infection Cohort Study

    Article • Clinical Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Peter Michael Keller

  39. Aortic Endograft Infection with Mycobacterium chimaera and Granulicatella adiacens, Switzerland, 2014

    Article • Emerging Infectious Diseases, September 2018, Centers for Disease Control and Prevention (CDC)

    Dr Peter Michael Keller

  40. Multiplex PCR on the Bronchoalveolar Lavage Fluid of Immunocompromised Patients

    Article • CHEST Journal, September 2018, Elsevier

    Dr Peter Michael Keller

  41. Comparison of Löwenstein–Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV

    Article • HIV Medicine, July 2018, Wiley

    Dr Peter Michael Keller

  42. Urban transmission of tuberculosis in China

    Article • The Lancet Infectious Diseases, July 2018, Elsevier

    Dr Peter Michael Keller

  43. Detection limit of Mycobacterium chimaera in water samples for monitoring medical device safety: insights from a pilot experimental series

    Article • Journal of Hospital Infection, July 2018, Elsevier

    Dr Peter Michael Keller

  44. Increased Pathogen Identification in Vascular Graft Infections by the Combined Use of Tissue Cultures and 16S rRNA Gene Polymerase Chain Reaction

    Article • Frontiers in Medicine, June 2018, Frontiers

    Dr Peter Michael Keller

  45. Different Types of Heater-Cooler Units and Their Risk of Transmission of Mycobacterium chimaera During Open-Heart Surgery: Clues From Device Design

    Article • Infection Control, May 2018, Cambridge University Press

    andreas widmer, Dr Peter Michael Keller

  46. Molecular detection of fungal pathogens in clinical specimens by 18S rDNA high-throughput screening in comparison to ITS PCR and culture

    Article • Scientific Reports, May 2018, Springer Science + Business Media

    Dr Peter Michael Keller

  47. Reply

    Article • Ophthalmology, May 2018, Elsevier

    Dr Peter Michael Keller

  48. Combining forecast probabilities with graphical visualization for improved reporting of antimicrobial susceptibility testing

    Article • Journal of Antimicrobial Chemotherapy, April 2018, Oxford University Press (OUP)

    Dr Peter Michael Keller

  49. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study

    Article • The Lancet Infectious Diseases, April 2018, Elsevier

    Professor JEROME ROBERT, Dr Peter Michael Keller

  50. Detection of respiratory bacterial pathogens causing atypical pneumonia by multiplex Lightmix ® RT-PCR

    Article • International Journal of Medical Microbiology, April 2018, Elsevier

    Dr Peter Michael Keller

  51. Global Health Estimate of Invasive Mycobacterium chimaera Infections Associated with Heater–Cooler Devices in Cardiac Surgery

    Article • Emerging Infectious Diseases, March 2018, Centers for Disease Control and Prevention (CDC)

    Dr Peter Michael Keller

  52. A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene

    Article • Diagnostic Microbiology and Infectious Disease, January 2018, Elsevier

    Dr Peter Michael Keller

  53. Pathogen Identification by Multiplex LightMix Real-Time PCR Assay in Patients with Meningitis and Culture-Negative Cerebrospinal Fluid Specimens

    Article • Journal of Clinical Microbiology, December 2017, ASM Journals

    Dr Peter Michael Keller

  54. Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.

    Article • Journal of Antimicrobial Chemotherapy, November 2017, Oxford University Press (OUP)

    Dr Peter Michael Keller

  55. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study

    Article • The Lancet Infectious Diseases, October 2017, Elsevier

    Dirk Wagner, Dr Peter Michael Keller

  56. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus

    Article • Journal of Antimicrobial Chemotherapy, September 2017, Oxford University Press (OUP)

    Dr Peter Michael Keller

  57. Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6–8 h by automated disc diffusion antibiotic susceptibility testing

    Article • Journal of Antimicrobial Chemotherapy, August 2017, Oxford University Press (OUP)

    Dr Peter Michael Keller

  58. MASTER: a model to improve and standardize clinical breakpoints for antimicrobial susceptibility testing using forecast probabilities

    Article • Journal of Antimicrobial Chemotherapy, July 2017, Oxford University Press (OUP)

    Dr Peter Michael Keller

  59. Asymptomatic congenital tuberculosis

    Article • Medicine, July 2017, Wolters Kluwer Health

    Dr Peter Michael Keller

  60. Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13

    Article • Cell, July 2017, Elsevier

    Dr Peter Michael Keller

  61. Evaluation of the AID carbapenemase line probe assay for rapid detection and identification of carbapenemase genes in Gram-negative bacilli

    Article • Journal of Antimicrobial Chemotherapy, April 2017, Oxford University Press (OUP)

    Dr Peter Michael Keller

  62. Clinical and Histopathologic Ocular Findings in Disseminated Mycobacterium chimaera Infection after Cardiothoracic Surgery

    Article • Ophthalmology, February 2017, Elsevier

    Dr Peter Michael Keller

  63. Reemergence ofMycobacterium chimaerain Heater–Cooler Units despite Intensified Cleaning and Disinfection Protocol

    Article • Emerging Infectious Diseases, October 2016, Centers for Disease Control and Prevention (CDC)

    Dr Peter Michael Keller

  64. Comment on: Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system

    Article • Journal of Antimicrobial Chemotherapy, August 2016, Oxford University Press (OUP)

    Dr Peter Michael Keller

  65. Diagnostic Molecular Mycobacteriology in Regions With Low Tuberculosis Endemicity: Combining Real-time PCR Assays for Detection of Multiple Mycobacterial Pathogens With Line Probe Assays for Identification of Resistance Mutations

    Article • EBioMedicine, July 2016, Elsevier

    Dr Peter Michael Keller

  66. Draft Genome Sequence of the Vaccination Strain Mycobacterium bovis BCG S4-Jena

    Article • Genome Announcements, April 2016, ASM Journals

    Dr Peter Michael Keller

  67. Performance of Copan WASP for Routine Urine Microbiology

    Article • Journal of Clinical Microbiology, March 2016, ASM Journals

    Dr Peter Michael Keller

  68. Delamanid and Bedaquiline Resistance inMycobacterium tuberculosisAncestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee

    Article • American Review of Respiratory Disease, February 2016, American Thoracic Society

    Dr Peter Michael Keller

  69. Restricted Identification of Clinical Pathogens Categorized as Biothreats by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry

    Article • Journal of Clinical Microbiology, January 2016, ASM Journals

    Dr Peter Michael Keller

  70. False low holotranscobalamin levels in a patient with a novel TCN2 mutation

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2016, De Gruyter

    Dr Peter Michael Keller

  71. Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2015, New England Journal of Medicine (NEJM/MMS)

    Dr Peter Michael Keller

  72. Determination of MIC Distribution and Epidemiological Cutoff Values for Bedaquiline and Delamanid in Mycobacterium tuberculosis Using the MGIT 960 System Equipped with TB eXiST

    Article • Antimicrobial Agents and Chemotherapy, May 2015, ASM Journals

    Dr Peter Michael Keller

  73. Detection of Pneumonia Associated Pathogens Using a Prototype Multiplexed Pneumonia Test in Hospitalized Patients with Severe Pneumonia

    Article • PLOS One, November 2014, PLOS

    Dr CATIA CILLONIZ, Dr Peter Michael Keller

  74. Primary Epstein–Barr virus infection and probable parvovirus B19 reactivation resulting in fulminant hepatitis and fulfilling five of eight criteria for hemophagocytic lymphohistiocytosis

    Article • International Journal of Infectious Diseases, November 2014, Elsevier

    Dr Peter Michael Keller

  75. A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon

    Article • BMC Clinical Pathology, May 2014, Springer Science + Business Media

    Dr Peter Michael Keller

  76. Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study

    Article • Drug Design Development and Therapy, February 2014, Taylor & Francis

    Dr Peter Michael Keller

  77. Non-invasive assessment of upper and lower airway infection and inflammation in CF patients

    Article • Pediatric Pulmonology, January 2014, Wiley

    Dr Peter Michael Keller

  78. Rational Therapy ofClostridium difficileInfections

    Article • Viszeralmedizin, January 2014, Karger Publishers

    Dr Peter Michael Keller

  79. HIV post exposure prophylaxis induced bicytopenia: a case report

    Article • AIDS Research and Therapy, January 2014, Springer Science + Business Media

    Dr Peter Michael Keller

  80. Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from Cystic Fibrosis patients during intravenous antibiotic treatment

    Article • BMC Pulmonary Medicine, January 2014, Springer Science + Business Media

    Dr Peter Michael Keller

  81. Epstein-Barr Virus MicroRNAs in Plasma as Potential Biomarkers for Chronic Infections: (Response to: Kawano et al; The Journal of Infectious Diseases; 2013; 208:771-9)

    Article • The Journal of Infectious Diseases, December 2013, Oxford University Press (OUP)

    Dr Peter Michael Keller

  82. Kutane Tuberkulosemanifestation als Ursache einer Wundheilungsstörung nach Bagatelltrauma

    Article • DMW - Deutsche Medizinische Wochenschrift, October 2013, Thieme Publishing Group

    Dr Peter Michael Keller

  83. Multiresistente Erreger

    Article • Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie, July 2013, Thieme Publishing Group

    Dr Peter Michael Keller

  84. Quality of blood culture testing - a survey in intensive care units and microbiological laboratories across four European countries

    Article • Critical Care, January 2013, Springer Science + Business Media

    Dr Peter Michael Keller

  85. Fieber und erniedrigte CD4-Zellzahl bei einem 22-jährigen Patienten aus Ghana

    Article • Der Internist, January 2013, Springer Science + Business Media

    Dr Peter Michael Keller

  86. Analysis of the Intestinal Microbiome of a Recovered Clostridium difficile Patient after Fecal Transplantation

    Article • Digestion, January 2013, Karger Publishers

    Dr Peter Michael Keller

  87. Close Geographic Association of Human Neoehrlichiosis and Tick Populations Carrying “Candidatus Neoehrlichia mikurensis” in Eastern Switzerland

    Article • Journal of Clinical Microbiology, October 2012, ASM Journals

    Dr Peter Michael Keller

  88. Family outbreak of an infection with a recombinant Coxsackie A virus in eastern Switzerland

    Article • Infection, October 2012, Springer Science + Business Media

    Dr Peter Michael Keller

  89. The Urinary Antibiotic 5-Nitro-8-Hydroxyquinoline (Nitroxoline) Reduces the Formation and Induces the Dispersal of Pseudomonas aeruginosa Biofilms by Chelation of Iron and Zinc

    Article • Antimicrobial Agents and Chemotherapy, August 2012, ASM Journals

    Dr Peter Michael Keller

  90. Streptococcus tigurinus, a Novel Member of the Streptococcus mitis Group, Causes Invasive Infections

    Article • Journal of Clinical Microbiology, July 2012, ASM Journals

    Dr Peter Michael Keller

  91. Vancomycin-resistant Enterococcus

    Article • Swiss Medical Weekly, May 2012, EMH Swiss Medical Publishers, Ltd.

    Dr Peter Michael Keller

  92. Afrikanisches Zeckenbissfieber - Rickettsiose nach Urlaub in Südafrika

    Article • DMW - Deutsche Medizinische Wochenschrift, April 2012, Thieme Publishing Group

    Dr Peter Michael Keller

  93. Streptococcus tigurinus sp. nov., isolated from blood of patients with endocarditis, meningitis and spondylodiscitis

    Article • INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, February 2012, Society for General Microbiology

    Dr Peter Michael Keller

  94. Broad-Range 16S rRNA Gene Polymerase Chain Reaction for Diagnosis of Culture-Negative Bacterial Infections

    Article • Clinical Infectious Diseases, October 2011, Oxford University Press (OUP)

    Dr Peter Michael Keller

  95. Relief from Zmp1-Mediated Arrest of Phagosome Maturation Is Associated with Facilitated Presentation and Enhanced Immunogenicity of Mycobacterial Antigens

    Article • Clinical and Vaccine Immunology, April 2011, ASM Journals

    Dr Peter Michael Keller

  96. Mycobacterium algericum sp. nov., a novel rapidly growing species related to the Mycobacterium terrae complex and associated with goat lung lesions

    Article • INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, September 2010, Society for General Microbiology

    Dr Peter Michael Keller

  97. Recognition of Potentially Novel Human Disease-Associated Pathogens by Implementation of Systematic 16S rRNA Gene Sequencing in the Diagnostic Laboratory

    Article • Journal of Clinical Microbiology, July 2010, ASM Journals

    Dr Peter Michael Keller

  98. Septicemia Caused by Tick-borne Bacterial Pathogen Candidatus Neoehrlichia mikurensis

    Article • Emerging Infectious Diseases, July 2010, Centers for Disease Control and Prevention (CDC)

    Dr Peter Michael Keller

  99. Detection of a Mixed Infection in a Culture-Negative Brain Abscess by Broad-Spectrum Bacterial 16S rRNA Gene PCR

    Article • Journal of Clinical Microbiology, April 2010, ASM Journals

    Dr Peter Michael Keller

  100. Cloning, expression and characterization of Mycobacterium tuberculosis lipoprotein LprF

    Article • Biochemical and Biophysical Research Communications, January 2010, Elsevier

    Dr Peter Michael Keller

  101. Deletion ofdopinMycobacterium smegmatisabolishes pupylation of protein substratesin vivo

    Article • Molecular Microbiology, December 2009, Wiley

    Dr Peter Michael Keller

  102. Identification of ApolipoproteinN-Acyltransferase (Lnt) in Mycobacteria

    Article • Journal of Biological Chemistry, August 2009, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Peter Michael Keller

  103. Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant

    Article • BMC Microbiology, January 2008, Springer Science + Business Media

    Dr Peter Michael Keller